Endocrinology

The committee meeting, tentatively scheduled for November 14, will have to precede the sNDA PDUFA action date set to review the drug's potential indication for reducing residual cardiovascular risks in patients with elevated triglycerides.

A recent study examining the effectiveness of an offline, automated smartphone-based AI system could be giving physicians a glimpse into the future of eye screening.

The parents of a 7-month-old girl brought their daughter to the ED after noticing that her skin was peeling all over her body. She also had diarrhea. What's your diagnosis?

Steven Edelman, MD, clinical professor of medicine at UC San Diego, discusses glucose control among pediatric patients after a trial into the efficacy of inhaled insulin opened enrollment earlier this week.

Physician from Palmetto Retina Center on deciding between aflibercept, ranibizumab, and avastin for treatment of DME.

A recent study published in the journal of the European Journal of Endocrinology found significant benefits of vitamin D supplementation on the development and progression of diabetes.

A systematic review and meta-analysis of observational studies assessing the association between plant-based dietary patterns and the risk of type 2 diabetes among adults, provides the strongest evidence to date that eating a plant-based diet does indeed lower the risk of type 2 diabetes.

Obesity was classified as a disease by the American Medical Association in 2013, but in the United Kingdom, experts are still grappling with whether they should follow suit. In this slideshow, we highlight positions on the issue.

Several new generics available to treat neuropathic pain linked to diabetic peripheral neuropathy, fibromyalgia partial onset seizures, and other conditions.

A recent study of more than 12 million people from 10 countries found that the risk of heart failure associated with diabetes was greater in women than in men. 



George Bakris, MD, outlines the difficulties clinicians face when treating diabetic kidney disease in an aging population.

A recent phase 2 trial found that caloric intake can improve biomarkers for heart disease, cancer, and cognitive decline — even among patients with a healthy BMI.

Death from acute stroke has dropped by as much as 55 percent, shows a population study published in BMJ.

A recent study of more than 50,000 found that antidepressant use could reduce a third of deaths among diabetic patients with depression.

How the institution has become involved in regional health education efforts, and national efforts to establish proper care protocol.

Late-in-life weight gain or weight loss appears to be associated with an increased risk of dementia, shows a Korean study of 67,219 men and women between 60-79 years old.

A new retrospective cohort finds that patients with untreated obstructive sleep apnea face a two-fold greater risk of developing T2D.

A recent study found that plant-based diets can lead to changes in gut microbiota that correlate with weightloss and fat reduction.

A single course of treatment with teplizumab delayed the development of type 1 diabetes in at-risk teens and children, shows a study presented at the American Diabetes Association annual meeting earlier this month.

Diabetes complications in young adults with type 2 diabetes are occurring in unusually high rates, researchers reported at the American Diabetes Association annual meeting held earlier this month in San Francisco.

Christopher Sorli, MD, vice president of medical affairs at Sanofi, discusses the results of a recent trial examining insulin glargine plus lixisenatide.

After Janssen's submission of an sNDA in March, results of the CREDENCE subgroup analyses were among the most anticipated presentations at ADA 2019.

A study presented at ADA 2019 examined the efficacy of sitagliptin compared with dapagliflozin in t2d patients 65 years old and older.

FDA has announced the approval of liraglutide injections for treatment of type 2 diabetes among pediatric patients.

A 6-month study examining the effects of hepatic-directed prandial insulin in patients with type 1 diabetes mellitus was presented at ADA 2019.

Investigators presented results of a study that analyzed renal function and markers of kidney damage in more than 1,000 patients in two randomized trials examining ertugliflozin.

A study analyzing the renal outcomes of the DECLARE-TIMI 58 trial were presented at ADA 2019 in San Francisco, CA.

A new study shows patients with T1D and comorbid cardiovascular disease face a signficantly greater cost of care.

A recent analysis of the BRIGHT trial examining renal function of insulin glargine 300u/mL versus insulin degludec 100u/mL was presented at ADA 2019.